Metrodora Institute
A medical and research center dedicated to advancing care and accelerating cures for people living with neuroimmune axis disorders.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
* | N/A | $35.0m | Late VC |
| Total Funding | 000k | ||
Related Content
Metrodora Institute is a pioneering medical center focused on the neuroimmune axis, which involves the interaction between the nervous and immune systems. The institute serves patients with complex neurological and immune disorders, offering a unique blend of clinical care and cutting-edge research. Operating in the healthcare sector, Metrodora collaborates with leaders in biotech, biopharma, and academia to drive medical discoveries and develop new treatments. The business model revolves around providing specialized medical services, conducting groundbreaking research, and forming strategic partnerships to advance healthcare. Revenue is generated through patient care services, research grants, and collaborative projects with industry leaders.
Keywords: neuroimmune axis, clinical care, research, biotech partnerships, biopharma, neurological disorders, immune disorders, advanced treatments, healthcare innovation, patient advocacy.